Home › Idiopathic Pulmonary Fibrosis › Ohio
Idiopathic Pulmonary Fibrosis clinical trials in Ohio
5 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in Ohio.
Cities in Ohio
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- University of Cincinnati, Cincinnati
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06951217A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Research Site, Cincinnati
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 21, 2026 · NCT07652658RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Cleveland Clinic, Cleveland
- The Ohio State University, Department of Psychiatry, Columbus
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- University of Cincinnati Medical Center, Cincinnati
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT06968845Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Cleveland Clinic, Cleveland
- The Ohio State University, Columbus
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.